Hi Dr. Hilary Jones MBE, GP living with HIV here 🙋People with #HIV & undetectable viral load are unlikely to infect others. This includes health care workers like surgeons #uequalsu. I wrote about this 10 years ago The BMJ bmj.com/content/344/bm… free link: core.ac.uk/reader/1311490…

It’s #TransDayOfVisibility! Trans & non-binary people deserve inclusive sexual health information specific to their bodies & realities. Led by & featuring trans, non-binary & gender diverse people, that’s what our inclusive & accessible sexual health information does⬇️ #TDOV

Something to listen to in the queue for petrol ⛽️ #petrol #panicbuying #brexit Original tune by: BLUE NEXT

Thanks for having me BHIVA!

bit.ly/3yk65yL Nearly 1 in 2 men who have sex with men and transgender women presenting with proctitis were not on #PrEP in a single UK centre. Reasons include poor access to HIV-PrEP and having a low perceived risk of HIV.

bit.ly/3yk65yL Nearly 1 in 2 men who have sex with men and transgender women presenting with proctitis were not on #PrEP in a single UK centre. Reasons include poor access to HIV-PrEP and having a low perceived risk of HIV.

The #IMPALA study has successfully recruited its 1st participant in a trial examining the effectiveness of long-acting cabotegravir & rilpivirine given by 2-monthly injections in adults with a history of sub-optimal #HIV control in sub-Saharan Africa Fiona Cresswell

Extremely delighted and grateful to have been awarded one of the 2023/24 CREATE PhD Programme Fellowships. Very excited to start the work at MRC/UVRI and LSHTM Uganda Research Unit and Global Health @BSMS early next year!

Brilliant news, many congratulations Claire VN. Looking forward to the results of your work on integrase inhibitor drug resistance in the context of long-acting injectable ART - important data for programmes and policy makers 🧬🦠 MRC/UVRI and LSHTM Uganda Research Unit @Nicholas_Bbosa_ Pontiano Kaleebu

All 7 collaborating sites in #IMPALA trial are now officially open. Together we'll answer the question of whether injectable #HIV therapy is an effective treatment option for people with adherence challenges The Joint Clinical Research Centre, Uganda Infectious Diseases Institute, Makerere University Desmond Tutu Health Foundation CAPRISA University of Nairobi 🇺🇬🇿🇦🇰🇪

CREATE PhD Programme @ZambartResearch London School of Hygiene & Tropical Medicine St George's, University of London (1752-2024) King's College London BSMS Queen Mary University of London Biomedical Research and Training Institute MRC/UVRI and LSHTM Uganda Research Unit MRC Unit The Gambia at LSHTM CDT-Africa Zvitambo Had a fab time at the pre meeting weekend trip to Vic Falls! 1000 thanks to Marcello Scopazzini and Claire Calderwood for fellow-herding, on to the week of science 🤓

Now Claire VN is talking us through her MRC/UVRI and LSHTM Uganda Research Unit study - looking at adherence and drug resistance with long acting injectable HIV prevention and treatment in Uganda CREATE PhD Programme #CreatePhD2024Lusaka

Delighted to be part of the CREATE PhD Programme meeting in🇿🇲 where BSMS students, fellows & supervisors are sharing their work. Pictured below are the BSMS delegation and Kate Mattick presenting her poster 👏🏽 #globalhealth #createphd2024lusaka

I (+ many others) have been affected by the double payments glitch DTB Uganda. Hundreds of pounds erroneously taken from our accounts, as recognised by DTB. Rather than support me, NatWest Group are not so subtly accusing me of fraud! Outrageous customer service. NatWest

This error has been recognised by DTB Uganda (statement below) yet Andy, myself, and many others have lost hundreds of £ and have been struggling to get our banks to resolve the issue (cc Monzo 🏦)

Thank you for having me Women & HIV, and what a fantastic workshop! I'm already excited for next year's edit #HIVWOMENAFRICA

2DR are not available in most HIV endemic settings & don't feature in WHO guidelines. We discuss benefits & risks of 2DR in the public health approach. We propose that DTG/3TC is an essential HIV treatment option for adolescents & older PLWH. RCT needed? 💊authors.elsevier.com/c/1j07M8MsVody…

The IMPALA trial, a study testing the effectiveness of a 2-monthly long acting injectable HIV treatment has completed enrollment! With 540 participants across 7 sites in 3 sub-Saharan African countries, the study seeks to revolutionlise HIV care for people with a history of...

🚀We're delighted to have launched a new campaign to highlight the Genitourinary Medicine (GUM) specialty! From managing STIs and HIV to providing essential contraception, GUM offers meaningful and rewarding opportunities. Join us 🌟 #LoveGUM More info 👉lovegum.bashh.org